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ABSTRACT 
Since very long period of time medicinal plants or their bioactive compounds have been utilized by majority of world 
population particularly in developing countries for primary and traditional healthcare system. At present scenario, 
people are more interested to use herbal drugs because they are considered as safe and inexpensive having no adverse 
effects. Different parts of the plants like roots, leaves, stem, bark, fruits and seeds have been used in treatment of 
different diseases and strengthening the immune system.  Murraya koenigii, is a herb from mainly Asian origin, it has 
therapeutic applications such as in bronchial disorders, piles, vomiting, skin diseases, night blindness, dysentery, 
diarrhoea, bites of poisonous animals, bruises and eruption etc. 
The present review is an attempt for description of M. koenigii, its phytochemical constituents and various 
pharmacological activities.  
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INTRODUCTION  
Murraya koenigii (family Rutaceae) is a herb 
having characteristic aroma and different potential 
medicinal values. It is deciduous shrub or tree up 
to 6 m in height and 15-40 cm in diameter with 
short trunk, thin smooth grey or brown bark and 
dense shady crown
1
.  
The most important chemical constitutents 
responsible for its intense characteristic aroma are 
P-gurjunene, P-caryophyllene, P-elemene and O-
phellandrene. The plant is rich source of carbazole  
 
 
 
alkaloids. Phytocompounds like koenimbine, 
koenine, mahanimbine, murrayazolidine, 
murrayazoline, murrayacine, girinimbine, mukoeic 
acid, etc. have also been isolated and 
characterized
2
. The stem of M. koenigii is an 
aromatic and more or less deciduous shrub or 
small tree upto 6 meters in height and 15 to 40 cm 
in diameter. The main stem is dark green to 
brownish. The bark of the stem can be peeled off 
longitudinally which exposes the white wood 
underneath. Flowers are small, white fragrant 
ebracteate, calyx deeply five cleft, pubescent
3
. 
Petals five, free, whitish, glabrous and with dotted 
glands. Fruits occur in close clusters, small ovoid 
or sub-globose, glandular, thin pericarp enclosing 
one or two seeds having spinach  
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green color
4
. Fresh leaves, dried leaf powder, and 
essential oil are widely used for flavouring soups, 
curries, fish and meat dishes, eggs dishes, 
traditional curry powder blends, seasoning and 
ready to use other food preparations. Bark and 
roots are used as stimulant and externally to cure 
eruptions and bites of poisonous animals
5
.  
It is traditionally used as a whole or in parts as 
anti-emetics, anti-diarrheal, febrifuge, blood 
purifier, antifungal, depressant, anti-inflammatory, 
body aches, for kidney pain and vomiting.  
Green leaves are eaten raw for cure of dysentery, 
diarrhoea and for checking vomiting
6
. 
Leaves and roots are also used traditionally as 
bitter, anthelmintic, analgesic, curing piles, 
inflammation, itching and are useful in leucoderma 
and blood disorders
7
.  
         Table 1: Botany of plant 
Kingdom Plantae 
Sub-kingdom Tracheobionta 
Superdivision Spermatophyta 
Division Magnoliophyta 
Class Magnoliospida 
Subclass Rosidae 
Order Sapindales 
Family Rutaceae 
Species Murraya koenigii L. 
Spreng 
Flowers are white, ebracteate, scented and small in 
size. Calyx deeply five cleft, pubescent. Petals 
five, free, whitish, glabrous and with dotted 
glands. It bears fruits in close clusters/ bunches, 
small, ovoid or sub-glucose, glandular, thin 
pericarp enclosing one or two seeds having spinach 
green color. 
Origin and Distribution  
Murraya koenigii is basically found in tropical 
Asia like the foothills of Himalayas of India, Sri 
Lanka, Myanmar, Indonesia, Southern China and  
 
 
 
 
Hainan. It reproduces the means of seeds which 
germinate freely under partial shade. It is also 
available in other part of Asian region like in moist 
forests of 500-1600m height in Guangdong, S 
Hainan, S Yunnan (Xishuang banna), Bhutan, 
Laos, Nepal, Pakistan, Sri Lanka, Thailand, 
Vietnam. Together with South Indian immigrants, 
curry leaves reached Malaysia, South Africa and 
Réunion Island. They are hardly found outside the 
Indian sphere of influence
8
. 
      
     (a). Whole plant                   (b).  Leaves        
                 Figure 1: Murraya koenigii 
PHYTOCHEMISTRY 
Murraya koenigii is a rich source of different 
organic compounds with diverse chemical 
composition.  
Leaves 
Fresh young leaves contains yellow colored 
volatile oil rich in vitamin A, calcium, girinimbin, 
iso-mahanimbin, koenine, koenigine, koenidine 
and koenimbine Leaves are aromatic and contain 
proteins, carbohydrates, fiber, minerals, carotene, 
nicotinic acid and vitamin C. Mature leaves 
contains 63.2% moisture, 1.15% total nitrogen, 
6.15% fat, 18.92% total sugars, 14.6% starch, 
6.8% crude fiber, ash 13.06%, acid insoluble ash 
1.35%, alcohol soluble extractive 1.82%. The 
leaves contain high amount of oxalic acid, leaves 
also contains crystalline glycosides, carbazole 
alkaloids, koenigin, resin, fresh leaves contain  
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yellow color 2.5% volatile oil
9
. 
Bark 
Bark mainly contains the carbazole alkaloids as 
murrayacine, murrayazolidine, murrayazoline, 
mahanimbine, girinimbine, koenioline, 
xynthyletin. The alcoholic extract of stem bark 
shows the presence of koenigine-quinone A and 
koenigine quinone B
9
.  
Fruits 
The pulp of fruits contains 64.9% moisture, 
13.35% of vitamin C, 9.76% total sugar, 0.17% 
non-reducing sugar), trace amount of minerals 
(1.97% phosphorus, 0.082% potassium, 0.811% 
calcium, 0.166% magnesium and 0.007%  iron)
10
. 
Roots 
Roots contains murrayanol, mukoenine- A, -B and 
C and murrastifoline –F. bis – 2- hydroxy- 3- 
methyl carbazole, bismahanine, bi koeniquinone- 
A and bismurrayaquinone A, Koenoline (1- 
methoxy-3- hydroxy methyl carbazole). Roots 
were also found to contain girinimbine
11
. 
Seeds  
Mahanimbine, girinimbine, koenimbine, 
isomahanine and mahanine were isolated form 
seeds of M. koenigii
12
 . 
PHARMACOLOGICAL ACTIVITY PROFILE 
OF M. KOENIGII  
1. Antioxidant and free radical-scavenging 
activity:  
Antioxidant activity has been reported by a number 
of workers. In a study antioxidative properties of 
the extract of M.koenigii leaves were done using 
different solvents. They were evaluated on the 
basis of oil stability index together with their  
 
 
 
 
 
 
radical scavenging ability against 1-1-diphenyl-2-
picrylhydrazyl. The methylene chloride extract and 
the ethyl acetate soluble fraction of the 70 % 
acetone extract was prolonged
13,14
. 
2. Cytotoxic Activity- In a study the alkaloid 
koenoline isolated from the root bark of M. 
koenigii is found to exhibit cytotoxic activity 
against KB cell culture system
15
. Carbazole 
alkaloids isolated from the stems are found to have 
significant effects in the growth of the human 
leukaemia cell line HL-60. Mahanine, pyrafoline-
D and murrafoline-I (Carbazole alkaloids) showed 
significant cytotoxicity against HL-60 cells and 
cause a significant loss in mitochondrial membrane 
potential. The results obtained suggested it, s 
cytotoxic activity potential
16
.  
3. Hypoglycemic activity  
Leaves feeding produce hypoglycemia by 
increasing the hepatic glycogenesis as evident by 
increased activity of glycogen synthetase
17
. In a 
study a decrease in glycogenolysis and 
gluconeogenesis is reported and was evident form 
decreased activity of glycogen phosphorylase and 
gluconeogenic enzymes. A significant reduction in 
fasting blood sugar and postprandial blood sugar 
was observed by feeding (12 gm) leaves powder to 
non insulin dependent diabetes mellitus patients. 
The results obtained suggested it, s hypoglycemic 
activity potential
18
.  
4. Antimicrobial and anti-fungal activity  
In a study Murrayanine, girinimbine and 
mahanimbine isolated form stem bark showed anti 
fungal activity against human pathogenic fungi. 1- 
formyl-3 methoxy-6- methyl carbazole and 6,7-
dimethoxy-1- hydroxy-3- methyl carbazole were 
reported to possess antibacterial and anti fungal  
 
 
ISSN: 2456-8058                                                           CODEN (USA): UJPRA3                                                               64 
Chibueze  et al.                                                                      Universal Journal of Pharmaceutical Research 
 
 
 
property. Extract containing murrayanol and or 
isomahanine is used as microbicide in variety of 
industries due to high safety, strong activity, little 
odor and without coloring effect
19
.  
5. Anti-inflammatory activity 
In a study stem bark of alcoholic extract in a dose 
of 1 gm/kg body weight showed protective effect 
against carrageenan-induced inflammation. Crude 
root extract also showed anti-inflammatory activity 
in rat model. The mast cell stabilization and 
antihistaminic effects of EEMK were suggested to 
be the probable mechanisms for its anti- 
inflammatory action and thus attains its therapeutic 
value. Study concludes anti-inflammatory potential 
of M. koenigii
20
. 
6. Immunomodulatory activity 
In a study methanolic extract of M. koenigii 
showed significant increase in phagocytic index by 
rapid removal of carbon particles from blood 
stream. The extract also increased the antibody 
titre against ovalbumin and protection towards 
cyclophosphamide-induced myelosuppression in 
albino mice. Oral administration of the aqueous 
extract of leaves at doses of 250 and 500 mg/kg 
significantly enhanced the delayed-type 
hypersensitivity reaction induced by ovalbumin. 
The extract also potentiated the production of 
circulating antibody titre significantly in response 
to ovalbumin
21
. 
7.  Alzheimer disease therapy 
In a study administration ethanolic extract of M. 
Koenigii Leaves for 15 days produces significant 
dose-dependent improvement of memory. The 
results also indicated to reduce the brain 
cholinesterase activity and total cholesterol level.  
Diet rich in M. koenigii leaves produced significant  
 
 
 
 
dose dependent improvement in the memory scores 
of young and aged mice and significantly reduced 
the amnesia induced by scopolamine (0.4 mg/kg, 
intraperitoneally) and diazepam (1 mg/kg, 
intraperitoneally)
22
.  
8. Anti-obesity and anti-hyperlipidemic 
activities  
In a study the dichloromethane and ethyl acetate 
extracts of Murraya koenigii leaves significantly 
reduced the body weight gain, plasma total 
cholesterol and triglyceride levels significantly. 
The observed anti-obesity and antihyperlipidemic 
activities of these extract are correlated with the 
carbazole alkaloids, Mahanimbine. When it was 
given orally (30 mg/kg/day) significantly lowered 
the body weight gain. These findings demonstrate 
the excellent pharmacological potential of 
mahanimbine to prevent obesity
23
. 
9. Anti-amnesic and wound-healing activity- 
In a study aqueous extract of M. koenigii 
accelerates the wound-healing process by 
decreasing the surface area of the wound. Aqueous 
extract of leaves showed marked reduction in 
wound area in comparison with the control group 
from 4
th
 day onwards in albino rats by excision 
wound model
24
. 
10. Kidney protective activity 
In a study aqueous extract of leaves produced a 
significant dose- dependent decrease in serum urea 
and creatinine levels (P<0.001), and a marked 
increase in the levels of plasma antioxidant 
capacity (P<0.01) in diabetic rats, compared with 
the control (non-diabetic) subjects. Histological 
studies of the kidneys of these animals showed 
comparable tissue regeneration by the aqueous 
extract
25
.  
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11. Antipyretic activity  
In a study ethanolic extract of leaves of M. 
koenigii was investigated for antipyretic activity in 
rats using yeast-induced pyrexia model. Ethanolic 
extract at a single dose of 300 mg/kg produced 
significant antipyretic activity (P<0.01) in albino 
rats as compared with the standard drug 
paracetamol
26
.  
12. Anti-ulcer activity 
Antiulcer activity of aqueous and solvent ether 
extracts of Murraya koenigii was studied in 
reserpine induced gastric ulcer model in albino 
rats. Aqueous and solvent ether extracts of 
Murraya koenigii effective in gastric ulceration 
and suggested as protective as ranitidine.  
The extract dose of Murraya koenigii 200-400 
mg/kg produced significant inhibition of gastric 
secretion. The results obtained suggested that the 
extract possesses significant antiulcer activity
27
.  
13. Anti-trichomonal activity  
In a study carbazole alkaloids and their derivatives 
from M. koenigii leaves showed antitrichomonal 
activity against Trichomonas gallinae. Girinimbine 
and girinimbilol with IC50 values of 1.08 and 1.20 
mg/mL were the most active. Acetylation of 
girinimbilol and mahanimbilol improved their 
activities to 0.60 and 1.08 mg/Ml
28
. 
14. Anthelmintic activity  
Ethanolic and aqueous extracts from M. koenigii 
leaves were investigated for their anthelmintic 
activity against Pheretima posthuma. Both the 
extracts exhibited significant anthelmintic activity 
at concentration of 100 mg/mL. The alcoholic 
extract produced more significant anthelmintic 
activity than petroleum ether extract
29
. 
 
 
 
 
 
15. Cosmetic use 
 Hyaluronidase inhibitors are extracted from M. 
koenigii and are formulated in a cream base. M. 
koenigii extract is included in a skin-lightening 
cosmetic for its moisturizing, antioxidant and 
hyaluronidase inhibitory activity. Herbal 
composition containing M. koenigii stem extract as 
one of the ingredient showed skin lightening and 
rough skin improving effect. M. koenigii was 
studied for sun protection
30,31
. 
16. Anti-diarrhoeal activity  
In a study bioactive alkaloids like, kurryam and 
koenimbine obtained from fractionated n-hexane 
extract of the seeds of M. koenigii were showed 
inhibitory action in reference to castor oil-induced 
diarrhoea and prostaglandin E2-induced enter 
pooling in strain of Wistar rats in charcoal meal 
test in Wister rats, these compounds were found to 
exhibit significant reduction in gastrointestinal 
motility and play mandate role in studying the 
modulatory role in disease progression
32
. 
17. Anti-cancer Activity  
Intraperitoneal inoculation of Dalton’s Ascitic 
Lymphoma cells in the mice produced an 
enormous increase in the cancer cell count which 
indicated that there is progression of cancer in the 
animals
33
. The decrease in the cancer cell number 
observed in the ether extract of Murraya koenigii 
the treated mice of G4 indicates that the test drug 
is having significant inhibitory effect on the 
tumour cell proliferation. The increase in tumour 
weight of G2 may be due to accumulation of 
peritoneal fluid as an abnormal enlargement of 
peritoneal cavity was observed in tumour-induced 
mice. Treatment with extract of Murraya koenigii  
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reduced the tumour weight and hence increased the 
life span
34
.  
CONCLUSION  
At present scenario, people are moving towards the 
use of herbal medicine for any kind of treatment as 
it seems to be economical and more beneficial 
without any adverse effects. According to WHO 
(World Health Organization), 80% of the 
population of developing countries still rely on 
plant-based medicines. The presence of various 
beneficial constituents in plants has always 
motivated scientists to carry out research for 
investigations for finding new therapeutic agents 
for treatment of different diseases. Based on 
tremendous pharmacological activities and plenty 
of literature available, M. koenigii may be utilized 
to alleviate the symptoms of variety of diseases. 
Almost each and every part of the plant has 
numerous therapeutic values. Various parts of it 
have numerous medical applications; modern 
drugs can be developed after extensive 
investigation of its bioactivity, mechanism of 
action, pharmaco-therapeutics, toxicity and after 
proper standardization and clinical trials. Wide 
spread availability of M. koenigii makes it suitable 
candidate for further pre-clinical and clinical 
research. From the available literature it can be 
stated that Murraya koenigii is a versatile 
medicinal plant having rich source of biologically 
active compounds. Thus, it can be consider being a 
most suitable candidate for new drug discovery 
evaluated by means of scientific experimental 
animal models and clinical trials.  
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Table 2: Pharmacological activity shown by extract of different parts of Murraya koenigii 
S. N. Plant Part Pharmacological Activity Extract 
1.  Leaf Anti-inflammatory  Ethanol, petroleum ether, 
chloroform, methanol 
Anti-amnesic, memory enhancer, 
anti-tumor 
Petroleum ether 
Hypocholesterolemic, wound 
healing activity, anti-helminthic 
Ethanol 
Anti-fungal Petroleum ether, alcohol and 
acetone 
Analgesic and antinociceptive, 
radioprotective and 
chemoprotective, anti-oxidant, 
phagocytic activity, anti-lipid 
peroxidative 
Methanol 
Anti-ulcer, cardiovascular Aqueous 
2.  Bark, leaf Anti-bacterial Petroleum ether, alcohol 
3.  Stem bark Anti-cancer Petroleum ether 
4.  Seeds Antidiarrhoeal n-hexane 
5.  Roots, stem Cytotoxicity Aqueous 
6.  Leaf, fruit Anti-diabetic Aqueous, methanol 
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